Cyclacel Pharmaceuticals, Inc. (CYCC) Trades at $1.52 After Triangle; CENTERRA GOLD COMMON SHARES CANADA (CAGDF) Sellers Increased By 223.99% Their Shorts

April 17, 2018 - By Clifton Ray

CENTERRA GOLD INC COMMON SHARES CANADA (OTCMKTS:CAGDF) had an increase of 223.99% in short interest. CAGDF’s SI was 425,400 shares in April as released by FINRA. Its up 223.99% from 131,300 shares previously. With 148,800 avg volume, 3 days are for CENTERRA GOLD INC COMMON SHARES CANADA (OTCMKTS:CAGDF)’s short sellers to cover CAGDF’s short positions. The SI to CENTERRA GOLD INC COMMON SHARES CANADA’s float is 0.22%. The stock increased 1.60% or $0.0988 during the last trading session, reaching $6.2588. About 5,714 shares traded. Centerra Gold Inc. (OTCMKTS:CAGDF) has 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Cyclacel Pharmaceuticals, Inc. (CYCC) formed triangle with $1.61 target or 6.00% above today’s $1.52 share price. Cyclacel Pharmaceuticals, Inc. (CYCC) has $18.24M valuation. The stock decreased 2.25% or $0.03 during the last trading session, reaching $1.52. About 121,831 shares traded. Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) has declined 63.19% since April 17, 2017 and is downtrending. It has underperformed by 74.74% the S&P500.

Analysts await Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) to report earnings on May, 10. They expect $-0.13 EPS, up 65.79% or $0.25 from last year’s $-0.38 per share.

Centerra Gold Inc., a gold mining and exploration company, engages in the acquisition, exploration, development, and operation of gold properties in Asia, North America, and internationally. The company has market cap of $1.75 billion. The Company’s principal projects include Kumtor gold mine located in the Kyrgyz Republic; and the Mount Milligan mine located in Canada. It has a 8.74 P/E ratio. The firm also holds 100% interests in the Altan Tsagaan Ovoo exploration property located in Mongolia.